title: Quality of life and functional capacity can be improved in patients with Eisenmenger syndrome with oral sildenafil therapy.
authors.affiliation: Adult Congenital Heart Centre and Centre for Pulmonary Hypertension, Royal Brompton Hospital, London, UK.
authors.forename: Edgar L W
authors.initials: EL
authors.lastname: Tay
authors.forename: Maria
authors.initials: M
authors.lastname: Papaphylactou
authors.forename: Gerhard Paul
authors.initials: GP
authors.lastname: Diller
authors.forename: Rafael
authors.initials: R
authors.lastname: Alonso-Gonzalez
authors.forename: Ryo
authors.initials: R
authors.lastname: Inuzuka
authors.forename: Georgios
authors.initials: G
authors.lastname: Giannakoulas
authors.forename: Carl
authors.initials: C
authors.lastname: Harries
authors.forename: Stephen John
authors.initials: SJ
authors.lastname: Wort
authors.forename: Lorna
authors.initials: L
authors.lastname: Swan
authors.forename: Konstantinos
authors.initials: K
authors.lastname: Dimopoulos
authors.forename: Michael A
authors.initials: MA
authors.lastname: Gatzoulis
mesh_terms: D000284:Administration, Oral; D000328:Adult; D004541:Eisenmenger Complex / Q000188:drug therapy* / Q000503:physiopathology*; D017079:Exercise Tolerance / Q000187:drug effects*; D005260:Female; D006801:Humans; D008297:Male; D010879:Piperazines / Q000008:administration & dosage* / Q000009:adverse effects; D011446:Prospective Studies; D011687:Purines / Q000008:administration & dosage / Q000009:adverse effects; D011788:Quality of Life; D000068677:Sildenafil Citrate; D013450:Sulfones / Q000008:administration & dosage* / Q000009:adverse effects; D011795:Surveys and Questionnaires; D016896:Treatment Outcome; D014665:Vasodilator Agents / Q000008:administration & dosage* / Q000009:adverse effects; D055815:Young Adult
chemical_list: D010879:Piperazines; D011687:Purines; D013450:Sulfones; D014665:Vasodilator Agents; D000068677:Sildenafil Citrate